File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1126/science.aai8126
- Scopus: eid_2-s2.0-84987723710
- PMID: 27609872
- WOS: WOS:000382626800028
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Zika vaccine trials
| Title | Zika vaccine trials |
|---|---|
| Authors | |
| Keywords | consensus disease severity Ebola hemorrhagic fever human immune response |
| Issue Date | 2016 |
| Publisher | American Association for the Advancement of Science. The Journal's web site is located at http://sciencemag.org |
| Citation | Science, 2016, v. 353 n. 6304, p. 1094-1095 How to Cite? |
| Abstract | Promising data for candidate vaccines against Zika virus infection reported by Abbink et al. (1) on page 1129 of this issue raise hopes that one or more Zika virus vaccines may soon be ready for efficacy trials. Recent years have seen a barrage of emerging infectious diseases, including those caused by new pathogens such as Middle East respiratory syndrome (MERS) coronavirus, and those that are newly salient because of increased geographic spread, higher incidence, or genetic change, such as influenza A(H1N1)pdm09, Ebola virus, and Zika virus. Developing effective vaccines is a central goal for such pathogens. |
| Persistent Identifier | http://hdl.handle.net/10722/284471 |
| ISSN | 2021 Impact Factor: 63.714 2020 SCImago Journal Rankings: 12.556 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lipsitch, M | - |
| dc.contributor.author | Cowling, BJ | - |
| dc.date.accessioned | 2020-08-07T08:58:05Z | - |
| dc.date.available | 2020-08-07T08:58:05Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Science, 2016, v. 353 n. 6304, p. 1094-1095 | - |
| dc.identifier.issn | 0036-8075 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/284471 | - |
| dc.description.abstract | Promising data for candidate vaccines against Zika virus infection reported by Abbink et al. (1) on page 1129 of this issue raise hopes that one or more Zika virus vaccines may soon be ready for efficacy trials. Recent years have seen a barrage of emerging infectious diseases, including those caused by new pathogens such as Middle East respiratory syndrome (MERS) coronavirus, and those that are newly salient because of increased geographic spread, higher incidence, or genetic change, such as influenza A(H1N1)pdm09, Ebola virus, and Zika virus. Developing effective vaccines is a central goal for such pathogens. | - |
| dc.language | eng | - |
| dc.publisher | American Association for the Advancement of Science. The Journal's web site is located at http://sciencemag.org | - |
| dc.relation.ispartof | Science | - |
| dc.rights | Science. Copyright © American Association for the Advancement of Science. | - |
| dc.rights | This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in [Science Journal Title] on [Volume number and date], DOI: [insert DOI number]. | - |
| dc.subject | consensus | - |
| dc.subject | disease severity | - |
| dc.subject | Ebola hemorrhagic fever | - |
| dc.subject | human | - |
| dc.subject | immune response | - |
| dc.title | Zika vaccine trials | - |
| dc.type | Article | - |
| dc.identifier.email | Cowling, BJ: bcowling@hku.hk | - |
| dc.identifier.authority | Cowling, BJ=rp01326 | - |
| dc.description.nature | link_to_subscribed_fulltext | - |
| dc.identifier.doi | 10.1126/science.aai8126 | - |
| dc.identifier.pmid | 27609872 | - |
| dc.identifier.scopus | eid_2-s2.0-84987723710 | - |
| dc.identifier.hkuros | 312178 | - |
| dc.identifier.volume | 353 | - |
| dc.identifier.issue | 6304 | - |
| dc.identifier.spage | 1094 | - |
| dc.identifier.epage | 1095 | - |
| dc.identifier.isi | WOS:000382626800028 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0036-8075 | - |